Increased CD4 : CD8 ratio normalization with implementation of current ART management guidelines. (29th November 2020)
- Record Type:
- Journal Article
- Title:
- Increased CD4 : CD8 ratio normalization with implementation of current ART management guidelines. (29th November 2020)
- Main Title:
- Increased CD4 : CD8 ratio normalization with implementation of current ART management guidelines
- Authors:
- Zhabokritsky, Alice
Szadkowski, Leah
Cooper, Curtis
Loutfy, Mona
Wong, Alexander
McClean, Alison
Hogg, Robert S
Walmsley, Sharon L - Abstract:
- Abstract: Objectives: To determine the time to CD4 : CD8 ratio normalization among Canadian adults living with HIV in the modern ART era. To identify characteristics associated with ratio normalization. Patients and methods: Retrospective analysis of the Canadian Observational Cohort (CANOC), an interprovincial cohort of ART-naive adults living with HIV, recruited from 11 treatment centres across Canada. We studied participants initiating ART between 1 January 2011 and 31 December 2016 with baseline CD4 : CD8 ratio <1.0 and ≥2 follow-up measurements. Normalization was defined as two consecutive CD4 : CD8 ratios ≥1.0. Kaplan–Meier estimates and log-rank tests described time to normalization. Univariable and multivariable proportional hazards (PH) models identified factors associated with ratio normalization. Results: Among 3218 participants, 909 (28%) normalized during a median 2.6 years of follow-up. Participants with higher baseline CD4+ T-cell count were more likely to achieve normalization; the probability of normalization by 5 years was 0.68 (95% CI 0.62–0.74) for those with baseline CD4+ T-cell count >500 cells/mm 3 compared with 0.16 (95% CI 0.11–0.21) for those with ≤200 cells/mm 3 ( P < 0.0001). In a multivariable PH model, baseline CD4+ T-cell count was associated with a higher likelihood of achieving ratio normalization (adjusted HR = 1.5, 95% CI 1.5–1.6 per 100 cells/mm 3, P < 0.0001). After adjusting for baseline characteristics, time-dependent ART classAbstract: Objectives: To determine the time to CD4 : CD8 ratio normalization among Canadian adults living with HIV in the modern ART era. To identify characteristics associated with ratio normalization. Patients and methods: Retrospective analysis of the Canadian Observational Cohort (CANOC), an interprovincial cohort of ART-naive adults living with HIV, recruited from 11 treatment centres across Canada. We studied participants initiating ART between 1 January 2011 and 31 December 2016 with baseline CD4 : CD8 ratio <1.0 and ≥2 follow-up measurements. Normalization was defined as two consecutive CD4 : CD8 ratios ≥1.0. Kaplan–Meier estimates and log-rank tests described time to normalization. Univariable and multivariable proportional hazards (PH) models identified factors associated with ratio normalization. Results: Among 3218 participants, 909 (28%) normalized during a median 2.6 years of follow-up. Participants with higher baseline CD4+ T-cell count were more likely to achieve normalization; the probability of normalization by 5 years was 0.68 (95% CI 0.62–0.74) for those with baseline CD4+ T-cell count >500 cells/mm 3 compared with 0.16 (95% CI 0.11–0.21) for those with ≤200 cells/mm 3 ( P < 0.0001). In a multivariable PH model, baseline CD4+ T-cell count was associated with a higher likelihood of achieving ratio normalization (adjusted HR = 1.5, 95% CI 1.5–1.6 per 100 cells/mm 3, P < 0.0001). After adjusting for baseline characteristics, time-dependent ART class was not associated with ratio normalization. Conclusions: Early ART initiation, at higher baseline CD4+ T-cell counts, has the greatest impact on CD4 : CD8 ratio normalization. Our study supports current treatment guidelines recommending immediate ART start, with no difference in ratio normalization observed based on ART class used. … (more)
- Is Part Of:
- Journal of antimicrobial chemotherapy. Volume 76:Number 3(2021)
- Journal:
- Journal of antimicrobial chemotherapy
- Issue:
- Volume 76:Number 3(2021)
- Issue Display:
- Volume 76, Issue 3 (2021)
- Year:
- 2021
- Volume:
- 76
- Issue:
- 3
- Issue Sort Value:
- 2021-0076-0003-0000
- Page Start:
- 729
- Page End:
- 737
- Publication Date:
- 2020-11-29
- Subjects:
- Anti-infective agents -- Periodicals
Chemotherapy -- Periodicals
615.58 - Journal URLs:
- http://jac.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/jac/dkaa484 ↗
- Languages:
- English
- ISSNs:
- 0305-7453
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4939.100000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26968.xml